Systematic review of the prevalence of psychiatric illness and sleep disturbance as co-morbidities of HIV infection in the UK

Age, time living with diagnosed HIV infection, and self-rated health

(2016) JA McGowan et al.   HIV MEDICINE

HIV-associated neurocognitive disorder — pathogenesis and prospects for treatment

(2016) Deanna Saylor et al.   Nature Reviews Neurology

Examining the associations between HIV-related stigma and health outcomes in people living with HIV/AIDS: a series of meta-analyses

(2016) Sergio Rueda et al.   BMJ Open

Association Between Efavirenz as Initial Therapy for HIV-1 Infection and Increased Risk for Suicidal Ideation or Attempted or Completed Suicide

(2014) Katie R. Mollan et al.   ANNALS OF INTERNAL MEDICINE

Minimal Cognitive Impairment in UK HIV-Positive Men Who Have Sex With Men

(2014) Jeffrey McDonnell et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Health-related quality-of-life of people with HIV in the era of combination antiretroviral treatment: a cross-sectional comparison with the general population

(2014) Alec Miners et al.   Lancet HIV

Co-Morbidities in Persons Infected with HIV: Increased Burden with Older Age and Negative Effects on Health-Related Quality of Life

(2013) Alan T. Rodriguez-Penney et al.   AIDS PATIENT CARE AND STDS

Routine detection and management of neurocognitive impairment in HIV-positive patients in a UK centre

(2013) L J Haddow et al.   INTERNATIONAL JOURNAL OF STD & AIDS

Neurocognitive Function in HIV Infected Patients on Antiretroviral Therapy

(2013) Alan Winston et al.   PLoS One

Substance use is a risk factor for neurocognitive deficits and neuropsychiatric distress in acute and early HIV infection

(2012) Erica Weber et al.   JOURNAL OF NEUROVIROLOGY

Efavirenz associated with cognitive disorders in otherwise asymptomatic HIV-infected patients

(2011) N. Ciccarelli et al.   NEUROLOGY

Suicidal ideation in UK HIV clinic attenders

(2009) Lorraine Sherr et al.   AIDS